Stay updated on KN035 Anti-PD-L1 Clinical Trial
Sign up to get notified when there's something new on the KN035 Anti-PD-L1 Clinical Trial page.

Latest updates to the KN035 Anti-PD-L1 Clinical Trial page
- Check3 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check10 days agoChange DetectedThe site revision identifier in the footer was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe study page now shows a 403 Forbidden error. This blocks access to the study record content while the standard site chrome remains visible.SummaryDifference17%

- Check52 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a new release of the page; no substantive study information appears to have changed.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page now displays the full study record content (overview, design, eligibility, and locations) replacing the prior error page state. Additional metadata and resource links, including publications and PubMed references, are now visible as part of the record.SummaryDifference42%

- Check73 days agoChange DetectedRevision indicator updated from v3.6.4 to v3.6.5. This suggests a minor template or metadata update rather than changes to study details.SummaryDifference0.1%

Stay in the know with updates to KN035 Anti-PD-L1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035 Anti-PD-L1 Clinical Trial page.